MedPath

EFFECT OF MAHA MANJISHTATHY KASHAYAM(INTERNAL)AND AADUTHENDAPALAI VEMBU ENNAI (EXTERNAL)ON KALANJAGAPADAI(PSORIASIS)IN CHILDRE

Phase 3
Conditions
Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Registration Number
CTRI/2022/07/043877
Lead Sponsor
ational Institute of Siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Erythema thickness scaling with/without itching cracks followed by itching, dryness of skin.

2.Patient informant/Parent and Patient are willing to sign the informed consent form and assent form stating that he/she will consciously stick to the treatment during 60 days but can opt out of the trial of his/her own conscious discretion

3. Willing to cooperate for taking photographs whenever required with his/her consent.

Exclusion Criteria

1 Eczema

2 Psoriasis with evidence of any other skin diseases

3 Fungal infections

4 Systemic involvement

5 Lesions with secondary infections

6 Epilepsy

7Any other serious illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of trial drug measured using Psoriasis area Scoring Index(PASI)Timepoint: 60days
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath